Civic Intelligence

Bebpa Inc.

990EZ • Fiscal year 2014 • EIN 27-0339401

Jan 01, 2014 to Dec 31, 2014 • Filed on Jun 12, 2015

8307 Willow Tree WayCitrus Heights, CA 95621

(951) 659-1957

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2014

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2014

Net Margin

62nd percentile

9.0%

Higher net margin than 62% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Top Officer Pay

74th percentile

$0

Higher top officer pay than 74% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Asset Growth

63rd percentile

11%

Faster asset growth than 63% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Revenue Growth

84th percentile

44%

Faster revenue growth than 84% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Assets

Up

$175,706

Up $16,906 (+11%) from 2013

Net Assets

Up

$175,706

Up $16,906 (+11%) from 2013

Liabilities

-

No earlier filing loaded for comparison.

Revenue

Up

$188,664

Up $57,472 (+44%) from 2013

Expenses

Up

$171,758

Up $57,034 (+50%) from 2013

Net Income

Up

$16,906

Up $438 (+2.7%) from 2013

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2010: $97,044Liabilities 2010: $0Net Assets 2010: $97,0442010Assets 2011: $126,511Net Assets 2011: $126,5112011Assets 2012: $142,332Net Assets 2012: $142,3322012Assets 2013: $158,800Net Assets 2013: $158,8002013Assets 2014: $175,706Net Assets 2014: $175,7062014Assets 2015: $258,499Liabilities 2015: $0Net Assets 2015: $258,4992015Assets 2016: $281,282Liabilities 2016: $0Net Assets 2016: $281,2822016Assets 2017: $310,038Liabilities 2017: $0Net Assets 2017: $310,0382017Assets 2018: $377,145Liabilities 2018: $3,563Net Assets 2018: $373,5822018Assets 2019: $512,043Liabilities 2019: $8,902Net Assets 2019: $503,1412019Assets 2020: $745,332Liabilities 2020: $8,902Net Assets 2020: $736,4302020Assets 2021: $919,467Liabilities 2021: $8,973Net Assets 2021: $910,4942021Assets 2022: $1,054,621Liabilities 2022: $10,835Net Assets 2022: $1,043,7862022Assets 2023: $1,101,754Liabilities 2023: $11,705Net Assets 2023: $1,090,0492023Assets 2024: $1,239,787Liabilities 2024: $11,434Net Assets 2024: $1,228,3532024

Highlighted filing

2014

Assets$175,706
Liabilities-
Net Assets$175,706

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0Expenses 2010: $83,6572010Revenue 2011: $109,584Expenses 2011: $80,117Net Income 2011: $29,4672011Revenue 2012: $105,608Expenses 2012: $89,787Net Income 2012: $15,8212012Revenue 2013: $131,192Expenses 2013: $114,724Net Income 2013: $16,4682013Revenue 2014: $188,664Expenses 2014: $171,758Net Income 2014: $16,9062014Revenue 2015: $285,974Expenses 2015: $214,115Net Income 2015: $71,8592015Revenue 2016: $251,472Expenses 2016: $228,689Net Income 2016: $22,7832016Revenue 2017: $381,214Expenses 2017: $352,458Net Income 2017: $28,7562017Revenue 2018: $453,521Expenses 2018: $389,977Net Income 2018: $63,5442018Revenue 2019: $523,386Expenses 2019: $393,827Net Income 2019: $129,5592019Revenue 2020: $543,289Expenses 2020: $310,000Net Income 2020: $233,2892020Revenue 2021: $458,399Expenses 2021: $284,335Net Income 2021: $174,0642021Revenue 2022: $541,584Expenses 2022: $420,487Net Income 2022: $121,0972022Revenue 2023: $737,062Expenses 2023: $690,799Net Income 2023: $46,2632023Revenue 2024: $1,008,455Expenses 2024: $878,945Net Income 2024: $129,5102024

Highlighted filing

2014

Revenue$188,664
Expenses$171,758
Net Income$16,906
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
Jun 12, 2015
Return Version
2014v5.0
Gross Receipts
$188,664
Mission and Program Overview

Mission

Bepba provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community. The aim of this open discussion is to promote development of innovative approaches and solution thus facilitating safer and faster biopharmaceutical product development.

Program Services

DescriptionGrantsExpenses
ESTABLISHING, REVIEWING AND GOVERNING RECURRENT SCIENTIFIC CONFERENCES.-$115,014
ESTABLISHING, REVIEWING AND GOVERNING RECURRENT SCIENTIFIC CONFERENCES.--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
LAUREEN LITTLEPresident/Tr-$0--
STANLEY DEMINGDirector-$0--
JANE ROBINSONTrustee/Dire-$0--
BASSAM HALLIS PHDDirector-$0--
HANS-JOACHIM WALLNYDirector-$0--
MARTIN VANDERLAAN PHDDirector-$0--
Filing and Contact Details

Filer

Filer Name
Bebpa Inc
EIN
27-0339401
Phone
9516591957
Address
8307 WILLOW TREE WAY, CITRUS HEIGHTS, CA 95621

Signing Officer

Name
Laureen Little
Title
President
Phone
9516591957
Signed
2015-06-12
Discuss with paid preparer
Yes

Preparer

Firm
Deborah J Kent Cpa-apac
Address
44550 VILLAGE COURT SUITE 103, PALM DESERT, CA 92260
Preparer
Deborah J Kent CPA
Phone
7603409200
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses promotion 2,193 supplies 1,865 taxes & licenses 110 supplies 2,552 computer meeting site 1,288 computer program 3,084 website construction 15 travel-bioassay meeting 5,439 travel -hcp 4,994 honorarium 13,675 hotel meeting fees 65,872 hotel accomodations 6,545 dining & entertainment 3,031 total 110,663

Form 990-ez, Part II, Line 24

Accounts receivable 0 3,315 total 0 3,315

Form 990-ez, Part III

Bepba provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community. The aim of this open discussion is to promote development of innovative approaches and solution thus facilitating safer and faster biopharmaceutical product development.

Form 990-ez, Part III, Line 31

Establishing, reviewing and governing recurrent scientific conferences.

Raw XML Appendix151 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0DEBORAH J KENT CPA
IRS990EZ/BooksInCareOfDetail/PhoneNum07603409200
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt044550 VILLAGE COURT 103
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0PALM DESERT
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092260
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0158800
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0172391
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt016906
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt055841
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0158800
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0175706
IRS990EZ/GrossReceiptsAmt0188664
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0158800
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0175706
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0158800
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0175706
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt0000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt1000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt3000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt4000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt5000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0LAUREEN LITTLE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1STANLEY DEMING
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2JANE ROBINSON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3BASSAM HALLIS PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4HANS-JOACHIM WALLNY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5MARTIN VANDERLAAN PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT/TR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2TRUSTEE/DIRE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5DIRECTOR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/EOYAmt03315
IRS990EZ/OtherExpensesTotalAmt0110663
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0BEPBA PROVIDES AN INTERNATIONAL FORUM FOR THE PRESENTATION AND DISCUSSION OF SCIENTIFIC ISSUES AND PROBLEMS ENCOUNTERED IN THE BIOPHARMACEUTICAL COMMUNITY. THE AIM OF THIS OPEN DISCUSSION IS TO PROMOTE DEVELOPMENT OF INNOVATIVE APPROACHES AND SOLUTION THUS FACILITATING SAFER AND FASTER BIOPHARMACEUTICAL PRODUCT DEVELOPMENT.
IRS990EZ/PrintingPublicationsPostageAmt05254
IRS990EZ/ProgramServiceRevenueAmt0188664
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0ESTABLISHING, REVIEWING AND GOVERNING RECURRENT SCIENTIFIC CONFERENCES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1ESTABLISHING, REVIEWING AND GOVERNING RECURRENT SCIENTIFIC CONFERENCES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0115014
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0171758
IRS990EZ/TotalProgramServiceExpensesAmt0115014
IRS990EZ/TotalRevenueAmt0188664
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.BEBPA.ORG
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt026073
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt024759
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt011024
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt019280
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt027570
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0108706
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0162592
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0105722
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt094584
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt090294
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt085113
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0538305
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt0647011
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0188665
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0130481
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0105608
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0109574
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0112683
IRS990ScheduleA/Total509Grp/TotalAmt0647011
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0188665
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0130481
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0105608
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0109574
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0112683
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0647011
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES PROMOTION 2,193 SUPPLIES 1,865 TAXES & LICENSES 110 SUPPLIES 2,552 COMPUTER MEETING SITE 1,288 COMPUTER PROGRAM 3,084 WEBSITE CONSTRUCTION 15 TRAVEL-BIOASSAY MEETING 5,439 TRAVEL -HCP 4,994 HONORARIUM 13,675 HOTEL MEETING FEES 65,872 HOTEL ACCOMODATIONS 6,545 DINING & ENTERTAINMENT 3,031 TOTAL 110,663
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ACCOUNTS RECEIVABLE 0 3,315 TOTAL 0 3,315
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2BEPBA PROVIDES AN INTERNATIONAL FORUM FOR THE PRESENTATION AND DISCUSSION OF SCIENTIFIC ISSUES AND PROBLEMS ENCOUNTERED IN THE BIOPHARMACEUTICAL COMMUNITY. THE AIM OF THIS OPEN DISCUSSION IS TO PROMOTE DEVELOPMENT OF INNOVATIVE APPROACHES AND SOLUTION THUS FACILITATING SAFER AND FASTER BIOPHARMACEUTICAL PRODUCT DEVELOPMENT.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3ESTABLISHING, REVIEWING AND GOVERNING RECURRENT SCIENTIFIC CONFERENCES.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 24
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III, LINE 31
ReturnHeader/BuildTS02016-02-25 16:41:14Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0LAUREEN LITTLE
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum09516591957
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-06-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0BEBPA INC
ReturnHeader/Filer/BusinessNameControlTxt0BEBP
ReturnHeader/Filer/EIN0270339401
ReturnHeader/Filer/PhoneNum09516591957
ReturnHeader/Filer/USAddress/AddressLine1Txt08307 WILLOW TREE WAY
ReturnHeader/Filer/USAddress/CityNm0CITRUS HEIGHTS
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd095621
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330772799
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0DEBORAH J KENT CPA-APAC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt044550 VILLAGE COURT SUITE 103
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0PALM DESERT
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd092260
ReturnHeader/PreparerPersonGrp/PhoneNum07603409200
ReturnHeader/PreparerPersonGrp/PreparationDt02015-06-12
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DEBORAH J KENT CPA
ReturnHeader/ReturnTs02015-09-09T18:37:07-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$1.24$0.01$1.23$1.01$0.88$0.13
2023Detailed filing. Detailed filing data is available for this year.$1.10$0.01$1.09$0.74$0.69$0.05
2022Detailed filing. Detailed filing data is available for this year.$1.05$0.01$1.04$0.54$0.42$0.12
2021Detailed filing. Detailed filing data is available for this year.$0.92$0.01$0.91$0.46$0.28$0.17
2020Detailed filing. Detailed filing data is available for this year.$0.75$0.01$0.74$0.54$0.31$0.23
2019Detailed filing. Detailed filing data is available for this year.$0.51$0.01$0.50$0.52$0.39$0.13
2018Detailed filing. Detailed filing data is available for this year.$0.38$0.00$0.37$0.45$0.39$0.06
2017Detailed filing. Detailed filing data is available for this year.$0.31$0.00$0.31$0.38$0.35$0.03
2016Detailed filing. Detailed filing data is available for this year.$0.28$0.00$0.28$0.25$0.23$0.02
2015Detailed filing. Detailed filing data is available for this year.$0.26$0.00$0.26$0.29$0.21$0.07
2014Detailed filing. Detailed filing data is available for this year.$0.18$0.18$0.19$0.17$0.02
2013Detailed filing. Detailed filing data is available for this year.$0.16$0.16$0.13$0.11$0.02
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.14$0.14$0.11$0.09$0.02
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.13$0.13$0.11$0.08$0.03
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.10$0.00$0.10$0.08